Diabetic Therapy
METSIFERâ„¢ PG2
Glimepiride 2mg + Metformin 500mg + Pioglitazone 15mg
Dosage Form
Tablets (bi-layered)
Packing
10x15 Blister
MRP
₹1650
Prescribed By
Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine
Quick Facts
Form
Bi-Layered Tablets
Pack
10×15 Blister
MRP
₹1650
Prescribed By
Diabetologist, Endocrinologist, General Physician
Key Benefits
01
Stronger Glimepiride dose for patients needing more insulin stimulation.
02
Pioglitazone addresses insulin resistance at tissue level.
03
Three complementary mechanisms in one tablet.
04
Suitable for patients not adequately controlled on lower doses.
Mechanism of Action
Higher Glimepiride 2mg dose provides stronger insulin stimulation alongside Metformin's insulin sensitisation and Pioglitazone's insulin resistance reduction. Comprehensive control across multiple blood sugar pathways.
Indications
Type 2 diabetes with insulin resistance requiring stronger Glimepiride-based combination therapy.
Dosage & Administration
Take as prescribed by your doctor or healthcare professional. Do not self-medicate.
Why METSIFERâ„¢ PG2?
METSIFER PG2 is the higher-dose triple combination for patients with significant insulin resistance and inadequate control on standard doses — providing thorough glucose management across three mechanisms.
